Related Posts
OPTALYSE PE: BTG RESULTS REINFORCE SAFETY, EFFICACY OF SHORTER, LOWER DOSE EKOS THERAPY FOR PE
BTG plc highlighted OPTALYSE PE one-year trial results, presented at the International Society on Endovascular…
CYNOSURE TOUTS TEMPSURE ENVI TO IMPROVE SKIN
Cynosure, now a part of Hologic, is releasing a radiofrequency system for performing aesthetic procedure on…
GE HEALTHCARE, LANTHEUS BEGIN A PHASE 3 CLINICAL TRIAL OF FLURPIRIDAZ TO TREAT CAD
GE Healthcare and Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., have started…
VEINPIX ALLOWS PATIENTS TO SEND LEG PIXS QUESTIONS FROM HOME
Realizing the benefits of telemedicine for both medical practices and their patients, Vein Specialists of…
